Article Details

FDA approves Roche's Susvimo, a first-of-its-kind therapeutic approach for neovascular or ...

Retrieved on: 2021-10-22 19:01:04

Tags for this article:

Click the tags to see associated articles and topics

FDA approves Roche's Susvimo, a first-of-its-kind therapeutic approach for neovascular or .... View article details on hiswai:

Excerpt

Basel, 22 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved Susvimo™ ...

Article found on: sports.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up